Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Shopify Inc. (SHOP) vs 22nd Century Group Inc (XXII) Price & Performance

Shopify Inc.Trade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Shopify Inc. vs 22nd Century Group Inc — how do they compare? Shopify Inc. trades at $122.56 (market cap $161.53B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Shopify Inc. is far larger — about 108409.4× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.

SHOPXXII
Market Cap
$161.53B$1.49M
Sector
TechnologyTechnology
52-Week High
$179.01$1.07K
52-Week Low
$95.40$3.90
Enterprise Value
$155.97B-$6.74M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Shopify Inc.

Shopify (SHOP) trades at $123.02, down 0.44% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q1 2026 EPS of $0.36, beating expectations, and shows strong revenue growth from $5.6B in 2022 to $11.6B in 2025. Operating cash flow improved to $2.03B in 2025, while net income reached $1.23B. Analyst sentiment is positive with a consensus price target of $148.54 and 66.7% buy ratings.

Outlook remains favorable due to revenue expansion and profitability gains, but high valuation ratios like P/E of 122.04 pose risks. Key opportunities include AI integration and global growth, while competition and economic sensitivity are concerns. The stock offers upside to analyst targets if execution continues.

22nd Century Group Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Shopify Inc.

Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.

Read more on SHOP

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII